503 related articles for article (PubMed ID: 32236445)
21. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients.
Elango T; Thirupathi A; Subramanian S; Dayalan H; Gnanaraj P
Clin Chim Acta; 2015 Dec; 451(Pt B):329-37. PubMed ID: 26499845
[TBL] [Abstract][Full Text] [Related]
23. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
24. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
[TBL] [Abstract][Full Text] [Related]
25. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
[TBL] [Abstract][Full Text] [Related]
26. Activation of the C3a anaphylatoxin receptor inhibits keratinocyte proliferation by regulating keratin 6, keratin 16, and keratin 17 in psoriasis.
Qiao P; Zhi D; Yu C; Zhang C; Wu K; Fang H; Shao S; Yin W; Dang E; Li K; Wang G
FASEB J; 2022 May; 36(5):e22322. PubMed ID: 35429062
[TBL] [Abstract][Full Text] [Related]
27. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
An J; Li Z; Dong Y; Ren J; Huo J
Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
[TBL] [Abstract][Full Text] [Related]
28. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
29. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
30. DZ2002 alleviates psoriasis-like skin lesions via differentially regulating methylation of GATA3 and LCN2 promoters.
Chen L; Lin Z; Liu Y; Cao S; Huang Y; Yang X; Zhu F; Tang W; He S; Zuo J
Int Immunopharmacol; 2021 Feb; 91():107334. PubMed ID: 33412493
[TBL] [Abstract][Full Text] [Related]
31. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
32. Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2.
Wei JA; Han L; Lu CJ; Zhao RZ; Sun J; Lu Y; Lin HJ
BMC Complement Altern Med; 2016 Jul; 16():255. PubMed ID: 27473420
[TBL] [Abstract][Full Text] [Related]
33. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
[TBL] [Abstract][Full Text] [Related]
34. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
[TBL] [Abstract][Full Text] [Related]
35. Orientin alleviates the inflammatory response in psoriasis like dermatitis in BALB/c mice by inhibiting the MAPK signaling pathway.
Long Q; Ma T; Wang Y; Chen S; Tang S; Wang T; Zhou Y; Xu K; Wan P; Cao Y
Int Immunopharmacol; 2024 Jun; 134():112261. PubMed ID: 38761783
[TBL] [Abstract][Full Text] [Related]
36. Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis.
Chen L; Huang D; Huang Z; Liu X; He M; Luo M; Tang Z; Tan G; Guo Q; Xiong H
Int Immunopharmacol; 2024 May; 133():112033. PubMed ID: 38608446
[TBL] [Abstract][Full Text] [Related]
37. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
[TBL] [Abstract][Full Text] [Related]
38. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways.
Zhuang Y; Han C; Li B; Jin L; Dang E; Fang H; Qiao H; Wang G
Arch Dermatol Res; 2018 Mar; 310(2):147-156. PubMed ID: 29349514
[TBL] [Abstract][Full Text] [Related]
39. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
Zhao K; Pu S; Sun L; Zhou D
Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
[TBL] [Abstract][Full Text] [Related]
40. C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes.
Chen C; Wu N; Duan Q; Yang H; Wang X; Yang P; Zhang M; Liu J; Liu Z; Shao Y; Zheng Y
Sci Rep; 2018 Jun; 8(1):8590. PubMed ID: 29872130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
